SYSTEMATIC REVIEW article
Front. Med.
Sec. Dermatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1503312
Emerging trends and hotspots in atopic dermatitis-related itch research over the past 10 years: A bibliometric and visual analysis
Provisionally accepted- 1Third Affiliated Hospital of Chongqing Medical University, Chongqing, China
- 2College of Basic Medical Sciences, Jinzhou Medical University, Jinzhou, Liaoning Province, China
- 3Chongqing Three Gorges Central Hospital, Chongqing, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Atopic dermatitis (AD) is a chronic inflammatory skin disorder that causes itching. While numerous studies on AD-related itch exist, a bibliometric analysis has not been performed on this topic. The study aimed to investigate research trends and hotspots in the field of AD-related itch over the last decade. We retrieved publications relevant to AD-related itch published from 2014 to 2023, within the Science Citation Index-Expanded of Web of Science Core Collection. We conducted a bibliometric and visual analysis involving annual publications, nations, institutions, journals, authors, co-citation references, and keywords by utilizing VOSviewer, CiteSpace, and the bibliometric online analysis platform. A total of 2534 articles and reviews were retrieved.Overall, the number of publications on AD-related itch has risen steadily over the past decade.The USA was found to be the most influential nation. Simpson et al. were found to be the most prolific author. Over the past 10 years, research has primarily revolved around barrier function, itching mechanism, sensory neurons, and therapeutic drugs for AD. The mechanisms of ADrelated itch and advanced drugs are the current research trends. This study can serve as a foundation for further research.
Keywords: bibliometric analysis, itch, Mechanism, Neuron, Dupilumab, atopic dermatitis
Received: 28 Sep 2024; Accepted: 26 May 2025.
Copyright: © 2025 Yu, Tao, Yang, Chen and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Bangtao Chen, Chongqing Three Gorges Central Hospital, Chongqing, China
Xiaoling Xue, College of Basic Medical Sciences, Jinzhou Medical University, Jinzhou, Liaoning Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.